Sign up for free insights newsletter
CR

Craneware Plc

CRWLondon Stock Exchange

Need professional-grade analysis? Visit stockanalysis.com

GBX 1,315.00
-1.87%
End of day
Market Cap

$490.02M

P/E Ratio

29.36

Employees

765

Dividend Yield

2.81%

Price Chart

Risk-Adjusted Performance

Ratio1W1M3M6M1Y5YScore
Sortino-1.34-1.47-2.68-2.34-1.03-0.27-1.41
Calmar-12.28-3.33-2.33-1.50-0.59-0.12-1.77
Sharpe-1.99-1.12-2.39-1.82-0.70-0.19-1.16
Omega0.000.750.450.610.891.000.74
Martin-16.75-7.82-3.94-2.87-1.38-0.24-3.19
Ulcer5.905.9919.9023.2020.8231.4621.59

Craneware Plc (CRW) Price Performance

Craneware Plc (CRW) trades on London Stock Exchange in GBX. The company is classified in the Healthcare sector under the Health Information Services industry. The stock currently trades at GBX1315.00, down 1.87% from the previous close.

Over the past year, CRW has traded between a low of GBX1315.00 and a high of GBX2577.52. The stock has lost 28.7% over this period. It is currently 49.0% below its 52-week high.

Craneware Plc has a market capitalization of $490.02M, with a price-to-earnings ratio of 29.36 and a dividend yield of 2.81%.

About Craneware Plc

Craneware plc, together with its subsidiaries, develops, licenses, and supports computer software for the healthcare industry in the United States. It provides solutions, such as Trisus Pricing Analyzer and Transparency, a solution that optimizes and automates the price modeling process; Trisus Chargemaster, an automated chargemaster management solution; InSight Medical Necessity, a solution that offers medical necessity requirements; Trisus Claims Informatics, a retrospective charge capture analytical application; Trisus Supply, a solution that improves supplies reimbursement; and InSight Audit, an audit solution for government and commercial payors. The company also offers Trisus Decision Support; Trisus Labor Productivity, which enables healthcare providers to manage, analyze, and plan the deployment of workforce; Trisus Medication Analytic solutions that prioritize, diagnose, and resolve issues in medication systems; and Trisus Supplies Assistant solutions which supplies charged data. In addition, it provides Sentrex, a SaaS-based solution that helps covered entities expand medication access; Sentinel, that tracks all drug activity; Referral Verification System; and Central Pharmacy Distribution, a centralized purchasing application. Further, the company offers professional, pharmacy professional, and appeal services. Additionally, the company provides The Academy, an interactive learning center for user training; Trisus Pricing Integrity Suite; Trisus Business of Pharmacy Suite, which offers solutions centered on each link in the medication revenue cycle; Trisus Value-based Margin and Productivity Suite; and Trisus Data Integrity Suite, which creates a proactive workflow that aligns data between operating units, the supply chain and revenue cycle. Craneware plc was incorporated in 1999 and is headquartered in Edinburgh, the United Kingdom.

Company Info

Exchange
London Stock Exchange
Currency
GBX

Financial Metrics

Revenue (TTM)
$211.33M
EBITDA
$30.02M
Profit Margin
10.64%
EPS (TTM)
0.47
Book Value
7.31

Technical Indicators

52 Week High
GBX 2,621.14
52 Week Low
GBX 1,302.37
50 Day MA
GBX 1,636.80
200 Day MA
GBX 2,054.90
Beta
-0.36

Valuation

Trailing P/E
29.36
Forward P/E
11.57
Price/Sales
2.32
Price/Book
1.93
Enterprise Value
$479.50M